SCHEMBL9611770

SCHEMBL9611770

Cc1ccccc1-c1c(C)cc(-c2ccc3cc(-c4cn5ccccc5n4)ccc3c2)c2ccccc12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 12/20 0.48
▸ NPC1 O15118 11/20 0.48
▸ KDM4E B2RXH2 9/20 0.48
▸ PKM P14618 5/20 0.48
▸ KMT2A Q03164 2/20 0.48
▸ GFER P55789 2/20 0.48
▸ EPHX2 P34913 1/20 0.48
▸ MEN1 O00255 1/20 0.48
▸ GAA P10253 1/20 0.48
▸ MIF P14174 1/20 0.48
▸ ALDH1A1 P00352 6/20 0.47
▸ SMN1; SMN2 Q16637 6/20 0.47
▸ MAPK1 P28482 3/20 0.47
▸ HPGD P15428 2/20 0.47
▸ TP53 P04637 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ HSD17B10 Q99714 1/20 0.47
▸ MAPT P10636 6/20 0.45
▸ POLB P06746 2/20 0.45
▸ NFKB1 P19838 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13454289 0.82 RAB9A (0.61) RAB9ANPC1KDM4EPKMKMT2A
SCHEMBL19726974 0.80 RAB9A (0.58) RAB9ANPC1KDM4EPKMKMT2A
SCHEMBL16622283 0.79 RAB9A (0.45) RAB9ANPC1KDM4EPKMKMT2A
SCHEMBL9976929 0.79 RAB9A (0.54) RAB9ANPC1KDM4EPKMKMT2A
SCHEMBL13454262 0.78 RAB9A (0.57) RAB9ANPC1KDM4EPKMKMT2A
SCHEMBL9611824 0.78 RAB9A (0.44) RAB9ANPC1KDM4EPKMKMT2A
SCHEMBL13454266 0.77 RAB9A (0.56) RAB9ANPC1KDM4EPKMKMT2A
SCHEMBL11885965 0.77 RAB9A (0.47) RAB9ANPC1KDM4EPKMKMT2A
SCHEMBL9976895 0.77 RAB9A (0.52) RAB9ANPC1KDM4EPKMKMT2A
SCHEMBL28615698 0.77 RAB9A (0.61) RAB9ANPC1KDM4EPKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120132899-A1 NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-31 — — US disclosed
US-20120132899-A1 NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME IDEMITSU KOSAN CO., LTD. (JP) 2012-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120132899-A1 NITROGENATED HETEROCYCLIC RING DERIVATIVE AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME H1-2, L1CAM, H1-0 RAB9A 1663/4885NPC1 1609/4885KDM4E 2763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback